Hydrogels Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Hydrogels Pipeline Market Report Overview

Hydrogels include dressings that consist of 96% water with a matrix of insoluble polymers embedded in it. The former helps to maintain a moist wound environment while the latter facilitates absorption of wound exudates. These dressings are available in the form of tubes and sheets and both of them are tracked under this segment. Hydrogels are segmented into antimicrobial and non-antimicrobial hydrogel dressings.

The Hydrogels pipeline market research report provides comprehensive information about the Hydrogels pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Territories ·        The US

·        China

·        Europe

·        Global

·        Australia

Key Segments ·        Antimicrobial Hydrogel Dressings

·        Non-Antimicrobial Hydrogel Dressings

Key Regulatory Paths ·        510(k)

·        NMPA

·        ICAC

·        TGA

·        Ninsho

Leading Companies ·        3QMatrix, Inc. (Inactive)

·        Abeona Therapeutics Inc

·        AgeX Therapeutics Inc

·        Alafair Biosciences Inc

·        Albert Ludwigs University of Freiburg

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Hydrogels Pipeline Market Segmentation by Segments

Some of the key segments in the Hydrogels market are Antimicrobial Hydrogel Dressings and Non-Antimicrobial Hydrogel Dressings. As of November 2023, Antimicrobial Hydrogel Dressings has the highest number of pipeline products.

Antimicrobial Hydrogel Dressings are dressings impregnated with an agent that inhibits microbial growth. Non-Antimicrobial Hydrogel Dressings are dressings devoid of antimicrobial activity due to the absence of antimicrobial agents.

Hydrogels Pipeline Market Analysis by Segments, 2023 (%)

Hydrogels Pipeline Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segments Insights into the Hydrogels Pipeline Market

Download a Free Report Sample

Hydrogels Pipeline Market Segmentation by Territories

Some of the key territories in the Hydrogels market are the US, China, Europe, Global, and Australia among others. As of November 2023, the US has the highest number of pipeline products.

Hydrogels Pipeline Market Analysis by Territories, 2023 (%)

Hydrogels Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Hydrogels Pipeline Market

Download a Free Report Sample

Hydrogels Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Hydrogels pipeline market are 510(k), NMPA, ICAC, TGA, and Ninsho. As of November 2023, 510(k) is the most followed pathway for pipeline products in the market.

Hydrogels Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Hydrogels Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Hydrogels Pipeline Market

Download a Free Report Sample

Hydrogels Pipeline Market – Competitive Landscape

Some of the key companies in the Hydrogels pipeline market are:

  • 3QMatrix, Inc. (Inactive)
  • Abeona Therapeutics Inc
  • AgeX Therapeutics Inc
  • Alafair Biosciences Inc
  • Albert Ludwigs University of Freiburg

Abeona Therapeutics Inc (Abeona). It, formerly PlasmaTech Biopharmaceuticals Inc., is a biopharmaceutical company that develops and delivers gene therapy and plasma-based products for severe life-threatening rare diseases. The company’s lead programs include EB-101, ABO-101 and ABO-102 adeno-associated virus. Abeona develops EB-101 for recessive dystrophic epidermolysis bullosa (RDEB), EB-201 for epidermolysis bullosa (EB), ABO-202 (AAV-CLN1) gene therapy for the treatment of infantile Batten disease (INCL), ABO-201 (AAV-CLN3) gene therapy for Juvenile Batten disease (JNCL) and more. The company has partnerships for the commercialization of its products in the US, European Union, Switzerland, Norway, Iceland, Lichtenstein, Australia, New Zealand, China and South Korea. Abeona is headquartered in New York City, the US.

Hydrogels Pipeline Market Analysis by Companies, 2023

Hydrogels Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Hydrogels Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Hydrogels Pipeline Market Segments Outlook

  • Antimicrobial Hydrogel Dressings
  • Non-Antimicrobial Hydrogel Dressings

Hydrogels Pipeline Market Territories Outlook

  • The US
  • China
  • Europe
  • Global
  • Australia

Hydrogels Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • NMPA
  • ICAC
  • TGA
  • NINSHO

Scope

This report provides:

  • Extensive coverage of the Hydrogels under development.
  • Review details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in pipeline product development and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data related to ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to – _x000D_

– Formulate significant competitor information, analysis, and insights to improve R&D strategies_x000D_

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage_x000D_

– Identify and understand important and diverse types of Hydrogels under development_x000D_

– Develop market-entry and market expansion strategies_x000D_

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline_x000D_

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

3QMatrix, Inc. (Inactive)
Abeona Therapeutics Inc
AgeX Therapeutics Inc
Alafair Biosciences Inc
Albert Ludwigs University of Freiburg
Amend Surgical, Inc.
Angiotech Pharmaceuticals Inc
AXXO Im- und Export GmbH
BioCure Inc
Biomendics LLC
Brigham and Women's Hospital
CelaCare Technologies LLC
Ceramicos Para Aplicacoes Medicas SA
Chi2Gel Ltd.
CorMedix Inc
Drexel University
Edixomed Ltd
Exogenus Therapeutics SA
Flexion Therapeutics Inc
Gel4Med Inc
Gelesis Inc
GelSana Therapeutics Inc
HyperBranch Medical Technology Inc
Icahn School of Medicine at Mount Sinai
In2cure AB
Indian Institute of Technology, Kanpur
Institute of Nano Science and Technology
Ionic Pharmaceuticals LLC
IPI Singapore
Jenarron Therapeutics Ltd
Johns Hopkins University
Kane Biotech Inc
Keratin Biosciences Inc
Magle Chemoswed AB
McMaster University
Missouri University of Science and Technology
Neotherix Ltd
Northwestern University
Novyx Technologies LLC
O2 Regentech LLC
Ohio State University
Orla Protein Technologies Ltd
Piramal Enterprises Ltd
Plurogen Therapeutics Inc (Inactive)
Queensland University of Technology
Quick-Med Technologies Inc
Quthero Inc
Regentys Corp
Scarless Laboratories Inc
SolasCure Ltd
Sonoma Pharmaceuticals Inc
Spanish National Research Council
Squid Healthcare Inc
Stanford University
Sunogel Biotechnologies Inc
SynDermix AG
Syracuse Biolabs Inc
Syracuse University
Tectum
Tel Aviv Sourasky Medical Center
Tel Aviv University
Texas Medical Center
Tokyo University of Science
University of California San Diego
University of Florida
University of Illinois at Chicago
University of Pennsylvania
University of Queensland
University of Wisconsin Madison
Ventrix Inc
VTT Technical Research Centre of Finland Ltd
Washington University in St Louis
Zeomedix, LLC

Table of Contents

1 Table of Contents 3

1.1 List of Tables 7

1.2 List of Figures 13

2 Introduction 14

2.1 Hydrogels Overview 14

3 Products under Development 15

3.1 Hydrogels – Pipeline Products by Stage of Development 15

3.2 Hydrogels – Pipeline Products by Segment 16

3.3 Hydrogels – Pipeline Products by Territory 17

3.4 Hydrogels – Pipeline Products by Regulatory Path 19

3.5 Hydrogels – Pipeline Products by Estimated Approval Date 20

3.6 Hydrogels – Ongoing Clinical Trials 21

4 Hydrogels – Pipeline Products under Development by Companies 22

4.1 Hydrogels Companies – Pipeline Products by Stage of Development 22

4.2 Hydrogels – Pipeline Products by Stage of Development 25

5 Hydrogels Companies and Product Overview 28

5.1 3QMatrix, Inc. (Inactive) Company Overview 28

5.1.1 3QMatrix, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 28

5.2 Abeona Therapeutics Inc Company Overview 29

5.2.1 Abeona Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.3 AgeX Therapeutics Inc Company Overview 30

5.3.1 AgeX Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.4 Alafair Biosciences Inc Company Overview 31

5.4.1 Alafair Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.5 Albert Ludwigs University of Freiburg Company Overview 33

5.5.1 Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 33

5.6 Amend Surgical, Inc. Company Overview 34

5.6.1 Amend Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

5.7 Angiotech Pharmaceuticals Inc Company Overview 35

5.7.1 Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 35

5.8 AXXO Im- und Export GmbH Company Overview 36

5.8.1 AXXO Im- und Export GmbH Pipeline Products & Ongoing Clinical Trials Overview 36

5.9 BioCure Inc Company Overview 38

5.9.1 BioCure Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.10 Biomendics LLC Company Overview 39

5.10.1 Biomendics LLC Pipeline Products & Ongoing Clinical Trials Overview 39

5.11 Brigham and Women’s Hospital Company Overview 42

5.11.1 Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 42

5.12 CelaCare Technologies LLC Company Overview 43

5.12.1 CelaCare Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 43

5.13 Ceramicos Para Aplicacoes Medicas SA Company Overview 46

5.13.1 Ceramicos Para Aplicacoes Medicas SA Pipeline Products & Ongoing Clinical Trials Overview 46

5.14 Chi2Gel Ltd. Company Overview 47

5.14.1 Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 47

5.15 CorMedix Inc Company Overview 48

5.15.1 CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.16 Drexel University Company Overview 50

5.16.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 50

5.17 Edixomed Ltd Company Overview 51

5.17.1 Edixomed Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

5.18 Exogenus Therapeutics SA Company Overview 56

5.18.1 Exogenus Therapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 56

5.19 Flexion Therapeutics Inc Company Overview 57

5.19.1 Flexion Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.20 Gel4Med Inc Company Overview 58

5.20.1 Gel4Med Inc Pipeline Products & Ongoing Clinical Trials Overview 58

5.21 Gelesis Inc Company Overview 61

5.21.1 Gelesis Inc Pipeline Products & Ongoing Clinical Trials Overview 61

5.22 GelSana Therapeutics Inc Company Overview 64

5.22.1 GelSana Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.23 HyperBranch Medical Technology Inc Company Overview 65

5.23.1 HyperBranch Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 65

5.24 Icahn School of Medicine at Mount Sinai Company Overview 66

5.24.1 Icahn School of Medicine at Mount Sinai Pipeline Products & Ongoing Clinical Trials Overview 66

5.25 In2cure AB Company Overview 67

5.25.1 In2cure AB Pipeline Products & Ongoing Clinical Trials Overview 67

5.26 Indian Institute of Technology, Kanpur Company Overview 70

5.26.1 Indian Institute of Technology, Kanpur Pipeline Products & Ongoing Clinical Trials Overview 70

5.27 Institute of Nano Science and Technology Company Overview 71

5.27.1 Institute of Nano Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 71

5.28 Ionic Pharmaceuticals LLC Company Overview 72

5.28.1 Ionic Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview 72

5.29 IPI Singapore Company Overview 73

5.29.1 IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 73

5.30 Jenarron Therapeutics Ltd Company Overview 75

5.30.1 Jenarron Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 75

5.31 Johns Hopkins University Company Overview 76

5.31.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 76

5.32 Kane Biotech Inc Company Overview 77

5.32.1 Kane Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 77

5.33 Keratin Biosciences Inc Company Overview 81

5.33.1 Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 81

5.34 Magle Chemoswed AB Company Overview 82

5.34.1 Magle Chemoswed AB Pipeline Products & Ongoing Clinical Trials Overview 82

5.35 McMaster University Company Overview 83

5.35.1 McMaster University Pipeline Products & Ongoing Clinical Trials Overview 83

5.36 Missouri University of Science and Technology Company Overview 84

5.36.1 Missouri University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 84

5.37 Neotherix Ltd Company Overview 85

5.37.1 Neotherix Ltd Pipeline Products & Ongoing Clinical Trials Overview 85

5.38 Northwestern University Company Overview 86

5.38.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 86

5.39 Novyx Technologies LLC Company Overview 90

5.39.1 Novyx Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 90

5.40 O2 Regentech LLC Company Overview 91

5.40.1 O2 Regentech LLC Pipeline Products & Ongoing Clinical Trials Overview 91

5.41 Ohio State University Company Overview 92

5.41.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 92

5.42 Orla Protein Technologies Ltd Company Overview 93

5.42.1 Orla Protein Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 93

5.43 Piramal Enterprises Ltd Company Overview 94

5.43.1 Piramal Enterprises Ltd Pipeline Products & Ongoing Clinical Trials Overview 94

5.44 Plurogen Therapeutics Inc (Inactive) Company Overview 95

5.44.1 Plurogen Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 95

5.45 Queensland University of Technology Company Overview 98

5.45.1 Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview 98

5.46 Quick-Med Technologies Inc Company Overview 99

5.46.1 Quick-Med Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 99

5.47 Quthero Inc Company Overview 100

5.47.1 Quthero Inc Pipeline Products & Ongoing Clinical Trials Overview 100

5.48 Regentys Corp Company Overview 101

5.48.1 Regentys Corp Pipeline Products & Ongoing Clinical Trials Overview 101

5.49 Scarless Laboratories Inc Company Overview 103

5.49.1 Scarless Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 103

5.50 SolasCure Ltd Company Overview 104

5.50.1 SolasCure Ltd Pipeline Products & Ongoing Clinical Trials Overview 104

5.51 Sonoma Pharmaceuticals Inc Company Overview 105

5.51.1 Sonoma Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 105

5.52 Spanish National Research Council Company Overview 106

5.52.1 Spanish National Research Council Pipeline Products & Ongoing Clinical Trials Overview 106

5.53 Squid Healthcare Inc Company Overview 107

5.53.1 Squid Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 107

5.54 Stanford University Company Overview 108

5.54.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 108

5.55 Sunogel Biotechnologies Inc Company Overview 109

5.55.1 Sunogel Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview 109

5.56 SynDermix AG Company Overview 111

5.56.1 SynDermix AG Pipeline Products & Ongoing Clinical Trials Overview 111

5.57 Syracuse Biolabs Inc Company Overview 112

5.57.1 Syracuse Biolabs Inc Pipeline Products & Ongoing Clinical Trials Overview 112

5.58 Syracuse University Company Overview 113

5.58.1 Syracuse University Pipeline Products & Ongoing Clinical Trials Overview 113

5.59 Tectum Company Overview 115

5.59.1 Tectum Pipeline Products & Ongoing Clinical Trials Overview 115

5.60 Tel Aviv Sourasky Medical Center Company Overview 116

5.60.1 Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 116

5.61 Tel Aviv University Company Overview 117

5.61.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 117

5.62 Texas Medical Center Company Overview 118

5.62.1 Texas Medical Center Pipeline Products & Ongoing Clinical Trials Overview 118

5.63 Tokyo University of Science Company Overview 119

5.63.1 Tokyo University of Science Pipeline Products & Ongoing Clinical Trials Overview 119

5.64 University of California San Diego Company Overview 120

5.64.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 120

5.65 University of Florida Company Overview 121

5.65.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 121

5.66 University of Illinois at Chicago Company Overview 122

5.66.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 122

5.67 University of Pennsylvania Company Overview 123

5.67.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 123

5.68 University of Queensland Company Overview 124

5.68.1 University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 124

5.69 University of Wisconsin Madison Company Overview 125

5.69.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 125

5.70 Ventrix Inc Company Overview 126

5.70.1 Ventrix Inc Pipeline Products & Ongoing Clinical Trials Overview 126

5.71 VTT Technical Research Centre of Finland Ltd Company Overview 127

5.71.1 VTT Technical Research Centre of Finland Ltd Pipeline Products & Ongoing Clinical Trials Overview 127

5.72 Washington University in St Louis Company Overview 128

5.72.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 128

5.73 Zeomedix, LLC Company Overview 129

5.73.1 Zeomedix, LLC Pipeline Products & Ongoing Clinical Trials Overview 129

6 Hydrogels- Recent Developments 130

6.1 Oct 27, 2023: ArcticZymes Technologies Invitation to Presentation of Q3 2023 Results 130

6.2 Oct 19, 2023: Piramal Enterprises to Raise Up to Rs 1,000 Crore 130

6.3 Oct 03, 2023: Baxter Appoints Joel Grade Chief Financial Officer 130

6.4 Oct 02, 2023: Advanced Medical Solutions Group Announces Appointment of New Chair 130

6.5 Sep 19, 2023: Baxter to Host Third-Quarter 2023 Financial Results Conference Call for Investors 131

6.6 Sep 14, 2023: Smith & Nephew Brings BT Chief Financial Officer Simon Lowth to Board 131

6.7 Sep 14, 2023: New Non Executive Directors Join the Board at Med Tech Business 132

6.8 Sep 14, 2023: Smith & Nephew Announces Board Changes 132

6.9 Aug 15, 2023: Convatec Group Appoints Robyn Butler-Mason as Company Secretary 133

6.10 Aug 14, 2023: ArcticZymes Technologies Announces Invitation to Presentation of Q2 2023 Results 133

6.11 Aug 14, 2023: NEXGEL Reports Second Quarter 2023 Record Revenue of $1.17 Million, an Increase of 108% Year-Over-Year 133

6.12 Aug 10, 2023: Advanced Medical Solutions Group Notice of Interim Results 134

6.13 Aug 03, 2023: Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year 135

6.14 Aug 02, 2023: ConvaTec Group Announces Interim Results for the six months ended 30 June 2023 136

6.15 Aug 01, 2023: S&T Researchers Developing New Dressings for Better Wound Care 136

6.16 Jul 17, 2023: Arcticzymes Technologies Appoints New CEO 137

6.17 Jun 26, 2023: Covalon Announces Participation in APIC Annual Conference & Exposition on June 26 – 28, 2023 in Orlando, Florida 138

6.18 Jun 07, 2023: Piramal Enterprises Releases Annual Report 138

6.19 Jun 06, 2023: ArcticZymes Technologies Announces Minutes form Annual General Meeting 2023 139

6.20 May 09, 2023: NEXGEL to report Q1 2023 financial results on May 15th 140

6.21 May 05, 2023: Piramal Enterprises reports audited financial results for quarter and year ended March 31, 2023 140

6.22 May 02, 2023: ArcticZymes Technologies Announces Annual Report 2022 140

6.23 Apr 27, 2023: ArcticZymes Technologies Announces Invitation to Presentation of Q1 2023 Results 140

6.24 Apr 26, 2023: Smith & Nephew announces Q1 2023 trading update 141

6.25 Apr 10, 2023: Henry Ford Health Appoints New Orthopedics Chair and Medical Director 143

6.26 Apr 06, 2023: Smith & Nephew Notice of First Quarter 2023 Trading Report 144

6.27 Mar 29, 2023: Baxter to Host Annual Meeting of Stockholders in Virtual Format 144

6.28 Mar 22, 2023: ArcticZymes Technologies announces CEO resignation 145

6.29 Mar 22, 2023: ConvaTec Group Notice of Annual General Meeting 145

6.30 Mar 15, 2023: NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th 146

6.31 Mar 09, 2023: ConvaTec Group Announces Annual Results for the twelve months ended 31 December 2022 146

6.32 Mar 09, 2023: Covalon Announces Voting Results from Fiscal 2022 Annual and Special Meeting of Shareholders 148

6.33 Mar 06, 2023: Smith & Nephew Announces Annual Financial Report 2022 148

6.34 Mar 06, 2023: Smith & Nephew Notice of 2023 Annual General Meeting 148

6.35 Feb 21, 2023: Smith & Nephew Announces Fourth Quarter and Full Year 2022 Results 149

6.36 Feb 09, 2023: Baxter Reports Fourth-Quarter and Full-Year 2022 Results 150

6.37 Jan 31, 2023: How to make hydrogels more injectable 152

6.38 Jan 17, 2023: NEXGEL Appoints Scott Henry CFA to Board of Directors and Audit Committee 154

6.39 Jan 03, 2023: Orthopedic biomaterials company appoints president, CEO 154

6.40 Dec 09, 2022: ArcticZymes Technologies upscales the production of ArcticZymes Proteinase and launches ArcticZymes Proteinase Glycerol FREE 154

6.41 Dec 01, 2022: ArcticZymes Technologies appoints a Chief Scientific Officer 155

6.42 Dec 01, 2022: NEXGEL to Host Fireside Chat with CEO Adam Levy on December 14th at 11:00 a.m. ET 156

7 Appendix 157

7.1 Methodology 157

7.2 About GlobalData 160

7.3 Contact Us 160

7.4 Disclaimer 160

Table

Hydrogels – Pipeline Products by Stage of Development 15

Hydrogels – Pipeline Products by Segment 16

Hydrogels – Pipeline Products by Territory 17

Hydrogels – Pipeline Products by Regulatory Path 19

Hydrogels – Pipeline Products by Estimated Approval Date 20

Hydrogels – Ongoing Clinical Trials 21

Hydrogels Companies – Pipeline Products by Stage of Development 22

Hydrogels – Pipeline Products by Stage of Development 25

3QMatrix, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 28

Bi-layer Dressing – Product Status 28

Bi-layer Dressing – Product Description 28

Abeona Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 29

BenzaGard – Product Status 29

BenzaGard – Product Description 29

AgeX Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 30

Renelon – Product Status 30

Renelon – Product Description 30

Alafair Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Alafair Bilayer – Product Status 31

Alafair Bilayer – Product Description 31

Alafair Injectable Gel – Product Status 32

Alafair Injectable Gel – Product Description 32

Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 33

PEG-Hydrogel – Product Status 33

PEG-Hydrogel – Product Description 33

Amend Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

Oral Hydrogel Adhesive – Product Status 34

Oral Hydrogel Adhesive – Product Description 34

Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Adhibit – Product Status 35

Adhibit – Product Description 35

AXXO Im- und Export GmbH Pipeline Products & Ongoing Clinical Trials Overview 36

AXXO Woundgel – Product Status 36

AXXO Woundgel – Product Description 37

BioCure Inc Pipeline Products & Ongoing Clinical Trials Overview 38

Growth Factor Delivery – Hydrogel Wound Dressing – Product Status 38

Growth Factor Delivery – Hydrogel Wound Dressing – Product Description 38

Biomendics LLC Pipeline Products & Ongoing Clinical Trials Overview 39

TolaSure Topical Gel – Acute Wounds – Product Status 39

TolaSure Topical Gel – Acute Wounds – Product Description 39

Tolasure Topical Gel – Burns – Product Status 40

Tolasure Topical Gel – Burns – Product Description 40

Tolasure Topical Gel – Chronic Wounds – Product Status 40

Tolasure Topical Gel – Chronic Wounds – Product Description 41

Tolasure Topical Gel – Skin Ulcers – Product Status 41

Tolasure Topical Gel – Skin Ulcers – Product Description 41

Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 42

ELP Hydrogel – Product Status 42

ELP Hydrogel – Product Description 42

CelaCare Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 43

OTC Antimicrobial Gel – Product Status 43

OTC Antimicrobial Gel – Product Description 43

Prescription Gel 1 – Product Status 44

Prescription Gel 1 – Product Description 44

Prescription Gel 2 – Product Status 44

Prescription Gel 2 – Product Description 45

Ceramicos Para Aplicacoes Medicas SA Pipeline Products & Ongoing Clinical Trials Overview 46

HidroKi – Product Status 46

HidroKi – Product Description 46

Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 47

Chi2Gel Wound Dressing – Product Status 47

Chi2Gel Wound Dressing – Product Description 47

CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview 48

CMDX-007 – Topical Hydrogel – Product Status 48

CMDX-007 – Topical Hydrogel – Product Description 48

CRMD-009 – Nanoparticle Hydrogel – Product Status 49

CRMD-009 – Nanoparticle Hydrogel – Product Description 49

Drexel University Pipeline Products & Ongoing Clinical Trials Overview 50

Immunomodulatory Hydrogel Dressing – Product Status 50

Immunomodulatory Hydrogel Dressing – Product Description 50

Edixomed Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

EDX110 – Burns – Product Status 51

EDX110 – Burns – Product Description 51

EDX110 – Cystic Fibrosis – Product Status 52

EDX110 – Cystic Fibrosis – Product Description 52

EDX110 – Diabetic Foot Ulcer – Product Status 52

EDX110 – Diabetic Foot Ulcer – Product Description 53

EDX110 – Pressure Ulcers – Product Status 53

EDX110 – Pressure Ulcers – Product Description 53

EDX110 – Septic Shock – Product Status 54

EDX110 – Septic Shock – Product Description 54

EDX110 – Surgical Wounds – Product Status 54

EDX110 – Surgical Wounds – Product Description 55

EDX110 – Venous Leg Ulcers – Product Status 55

EDX110 – Venous Leg Ulcers – Product Description 55

Exogenus Therapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 56

Exo-Wound – Product Status 56

Exo-Wound – Product Description 56

Flexion Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 57

FX301 – Product Status 57

FX301 – Product Description 57

Gel4Med Inc Pipeline Products & Ongoing Clinical Trials Overview 58

G4db – Product Status 58

G4db – Product Description 58

G4I – Product Status 59

G4I – Product Description 59

G4Surg – Product Status 59

G4Surg – Product Description 60

Gelesis Inc Pipeline Products & Ongoing Clinical Trials Overview 61

Gel-B – Product Status 61

Gel-B – Product Description 61

Gelesis Inc – Ongoing Clinical Trials Overview 62

Gel-B – A Randomized, Double-blind, Placebo-controlled, Parallel-group Study Assessing the Effect of GS300 on Nonalcoholic Fatty Liver Disease 63

GelSana Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 64

Hydrogel – Diabetic Foot Ulcer – Product Status 64

Hydrogel – Diabetic Foot Ulcer – Product Description 64

HyperBranch Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 65

Adherus MIS – Product Status 65

Adherus MIS – Product Description 65

Icahn School of Medicine at Mount Sinai Pipeline Products & Ongoing Clinical Trials Overview 66

FibGen – Product Status 66

FibGen – Product Description 66

In2cure AB Pipeline Products & Ongoing Clinical Trials Overview 67

TCP-25 – Product Status 67

TCP-25 – Product Description 67

In2cure AB – Ongoing Clinical Trials Overview 68

TCP-25 – A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Male and Female Volunteers to Investigate the Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds 69

Indian Institute of Technology, Kanpur Pipeline Products & Ongoing Clinical Trials Overview 70

Hydrogel Dressing – Chronic Wounds And Infection – Product Status 70

Hydrogel Dressing – Chronic Wounds And Infection – Product Description 70

Institute of Nano Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 71

Smart Injectable Hydrogel – Product Status 71

Smart Injectable Hydrogel – Product Description 71

Ionic Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview 72

HydrAid Burn Dressing – Product Status 72

HydrAid Burn Dressing – Product Description 72

IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 73

Hyaluronic Acid-Based Gel – Product Status 73

Hyaluronic Acid-Based Gel – Product Description 73

Keratin Hydrogel – Product Status 73

Keratin Hydrogel – Product Description 74

Jenarron Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 75

JA01 Lidocaine Rheo-Gel – Product Status 75

JA01 Lidocaine Rheo-Gel – Product Description 75

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 76

Chondroitin Sulfate Hydrogel – Product Status 76

Chondroitin Sulfate Hydrogel – Product Description 76

Kane Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 77

DispersinB Hydrogel – Product Status 77

DispersinB Hydrogel – Product Description 78

DispersinB Hydrogel – Prosthetic Joint Infection – Product Status 78

DispersinB Hydrogel – Prosthetic Joint Infection – Product Description 78

Kane Biotech Inc – Ongoing Clinical Trials Overview 79

DispersinB Hydrogel – A Study to Evaluate the Safety of DispersinB Hydrogel 80

Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 81

Keratin-Based Hydrogel Wound Dressing – Product Status 81

Keratin-Based Hydrogel Wound Dressing – Product Description 81

Magle Chemoswed AB Pipeline Products & Ongoing Clinical Trials Overview 82

SmartGel II – Product Status 82

SmartGel II – Product Description 82

McMaster University Pipeline Products & Ongoing Clinical Trials Overview 83

Antibacterial Phage Hydrogel – Product Status 83

Antibacterial Phage Hydrogel – Product Description 83

Missouri University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 84

3D-Printed Hydrogel Dressing – Product Status 84

3D-Printed Hydrogel Dressing – Product Description 84

Neotherix Ltd Pipeline Products & Ongoing Clinical Trials Overview 85

RegeniTherix – Product Status 85

RegeniTherix – Product Description 85

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 86

Biocompatible Hydrogel – Product Status 86

Biocompatible Hydrogel – Product Description 86

Copper Based Hydrogel Wound Dressing – Product Status 87

Copper Based Hydrogel Wound Dressing – Product Description 87

pH Responsive Self-Healing Hydrogel – Product Status 87

pH Responsive Self-Healing Hydrogel – Product Description 88

Thermoresponsive Cell Adhesive Bioresorbable Dressing – Product Status 88

Thermoresponsive Cell Adhesive Bioresorbable Dressing – Product Description 88

Tissue Sealant – Fetal Membrane Repair – Product Status 89

Tissue Sealant – Fetal Membrane Repair – Product Description 89

Novyx Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 90

Hydrogel Wound Dressing – Product Status 90

Hydrogel Wound Dressing – Product Description 90

O2 Regentech LLC Pipeline Products & Ongoing Clinical Trials Overview 91

OXAID – Product Status 91

OXAID – Product Description 91

Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 92

MG53 Hydrogel – Product Status 92

MG53 Hydrogel – Product Description 92

Orla Protein Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 93

Synthetic ECM Hydrogel – Product Status 93

Synthetic ECM Hydrogel – Product Description 93

Piramal Enterprises Ltd Pipeline Products & Ongoing Clinical Trials Overview 94

BST-DermOn – Product Status 94

BST-DermOn – Product Description 94

Plurogen Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 95

PluroGel PNN – Product Status 95

PluroGel PNN – Product Description 95

Plurogen Therapeutics Inc (Inactive) – Ongoing Clinical Trials Overview 96

PluroGel PNN – A Between Patient, Pilot Randomized Controlled Study of Plurogel Compared to Standard Topical Dressing in Burn Injuries 97

PluroGel PNN – A Within Patient, Pilot Randomized Controlled Study of Plurogel Compared to Standard Topical Dressing in Burn Injuries 97

Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview 98

Antibiotic Hydrogel – Product Status 98

Antibiotic Hydrogel – Product Description 98

Quick-Med Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 99

Nimbus Hydrogel – Product Status 99

Nimbus Hydrogel – Product Description 99

Quthero Inc Pipeline Products & Ongoing Clinical Trials Overview 100

Q-gel – Product Status 100

Q-gel – Product Description 100

Regentys Corp Pipeline Products & Ongoing Clinical Trials Overview 101

ECMH (Extracellular Matrix Hydrogel) – Crohn’s Disease – Product Status 101

ECMH (Extracellular Matrix Hydrogel) – Crohn’s Disease – Product Description 101

ECMH Rectal Solution – Ulcerative Colitis – Product Status 102

ECMH Rectal Solution – Ulcerative Colitis – Product Description 102

Scarless Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 103

HA-SLI-F06 Hydrogel – Product Status 103

HA-SLI-F06 Hydrogel – Product Description 103

SolasCure Ltd Pipeline Products & Ongoing Clinical Trials Overview 104

Aurase – Product Status 104

Aurase – Product Description 104

Sonoma Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 105

Microcyn Allergen Shield Hydrogel – Product Status 105

Microcyn Allergen Shield Hydrogel – Product Description 105

Spanish National Research Council Pipeline Products & Ongoing Clinical Trials Overview 106

Multicomponent Hydrogel – Product Status 106

Multicomponent Hydrogel – Product Description 106

Squid Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 107

EyeMask MD – Product Status 107

EyeMask MD – Product Description 107

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 108

Gel-Aid – Product Status 108

Gel-Aid – Product Description 108

Sunogel Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview 109

WizGel-DX1 – Product Status 109

WizGel-DX1 – Product Description 109

WizGel-DX2 – Product Status 110

WizGel-DX2 – Product Description 110

SynDermix AG Pipeline Products & Ongoing Clinical Trials Overview 111

PGX-10 – Product Status 111

PGX-10 – Product Description 111

Syracuse Biolabs Inc Pipeline Products & Ongoing Clinical Trials Overview 112

Hydrogel – Anti-Infection Wound Care Dressing – Product Status 112

Hydrogel – Anti-Infection Wound Care Dressing – Product Description 112

Syracuse University Pipeline Products & Ongoing Clinical Trials Overview 113

Antimicrobial Hydrogel Web – Product Status 113

Antimicrobial Hydrogel Web – Product Description 113

Shape Memory Polymer Hydrogel – Product Status 114

Shape Memory Polymer Hydrogel – Product Description 114

Tectum Pipeline Products & Ongoing Clinical Trials Overview 115

Wound Healing Gel – Product Status 115

Wound Healing Gel – Product Description 115

Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 116

Guided Regeneration Gel – Product Status 116

Guided Regeneration Gel – Product Description 116

Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 117

Self Assembled Peptide Hydrogel (SAPH) – Product Status 117

Self Assembled Peptide Hydrogel (SAPH) – Product Description 117

Texas Medical Center Pipeline Products & Ongoing Clinical Trials Overview 118

Extracellular Matrix Hydrogel Spray – Product Status 118

Extracellular Matrix Hydrogel Spray – Product Description 118

Tokyo University of Science Pipeline Products & Ongoing Clinical Trials Overview 119

Alkaline Hydrogel – Product Status 119

Alkaline Hydrogel – Product Description 119

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 120

Self Healing Hydrogel – Product Status 120

Self Healing Hydrogel – Product Description 120

University of Florida Pipeline Products & Ongoing Clinical Trials Overview 121

Hydrogel Device – Product Status 121

Hydrogel Device – Product Description 121

University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 122

Hydrogel – Wound Healing – Product Status 122

Hydrogel – Wound Healing – Product Description 122

University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 123

Self-Healing Hydrogel – Product Status 123

Self-Healing Hydrogel – Product Description 123

University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 124

Peptide Hydrogel – Product Status 124

Peptide Hydrogel – Product Description 124

University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 125

Hydrogel Microspheres – Product Status 125

Hydrogel Microspheres – Product Description 125

Ventrix Inc Pipeline Products & Ongoing Clinical Trials Overview 126

VentriGel – Product Status 126

VentriGel – Product Description 126

VTT Technical Research Centre of Finland Ltd Pipeline Products & Ongoing Clinical Trials Overview 127

3D Nanocellulose Hydrogel Device – Product Status 127

3D Nanocellulose Hydrogel Device – Product Description 127

Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 128

Oxygen-Releasing Hydrogel – Product Status 128

Oxygen-Releasing Hydrogel – Product Description 128

Zeomedix, LLC Pipeline Products & Ongoing Clinical Trials Overview 129

Zeomedix Hydrogel – Product Status 129

Zeomedix Hydrogel – Product Description 129

Glossary 159

Figures

Hydrogels – Pipeline Products by Stage of Development 15

Hydrogels – Pipeline Products by Segment 16

Hydrogels – Pipeline Products by Territory 17

Hydrogels – Pipeline Products by Regulatory Path 19

Hydrogels – Pipeline Products by Estimated Approval Date 20

Hydrogels – Ongoing Clinical Trials 21

Frequently asked questions

Hydrogels Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Hydrogels Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Hydrogels Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Hydrogels Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.